MDT Medtronic
Medtronic earnings company data as of 5:12 AM ET 10/30
- 0 of 1 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q4 | 17 Nov | EPS | 1.34 | — | — |
| Rev | — | — | — | ||
| FY2027 Q1 | 1 Sep | EPS | 1.38 | 1.14 | Miss -17.4% |
| Rev | $9.55B | $9.76B | Beat +2.2% |
Insider trades
Open-market buys and sales by MDT's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $8.7M sold by 2 insiders outside a trading plan
- $6M sold by 3 insiders under 10b5-1 plans
-
Michael Marinaro EVP, Pres MedSurg and AmericasPlanned sale$1M 10,420 shares at $96.00 9% of stakeTraded Oct 15 Filed Oct 16
-
Geoffrey Martha CEOPlanned sale$4.8M 50,000 shares at $95.00 15% of stakeTraded Oct 15 Filed Oct 16
-
Harry Skip Kiil EVP & President CardiovascularSale$139K 1,483 shares at $93.65 3.4% of stakeTraded Sep 16 Filed Sep 17
-
Matthew R. Walter SVP, Chief HR OfficerPlanned sale$258K 3,102 shares at $83.15 8% of stakeTraded Jul 8 Filed Jul 9
-
Harry Skip Kiil EVP & President CardiovascularSale$337K 4,189 shares at $80.44 10% of stakeTraded Jun 8 Filed Jun 9
-
Harry Skip Kiil EVP & President CardiovascularSale$5.1M 52,524 shares at $97.71 62% of stakeTraded Feb 19 Filed Feb 26
-
Gregory L Smith EVP Global Ops & Supply ChainSale$3.1M 30,000 shares at $101.95 40% of stakeTraded Nov 19, 2025 Filed Nov 21, 2025
Also filed in the last 12 months, not counted as buying or selling: 29 share withholdings for taxes, 21 stock grants, 9 option exercises, 3 gifts, and 1 other transaction.
SEC filings
Recent issuer filings from EDGAR, 7 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.